Andrew C. Stokes

Andrew C. Stokes

Auto-generated profile, based on publicly available information

Andrew C. Stokes

Department of Global Health, Boston University School of Public Health, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
JMJennifer Manne-Goehler
Jennifer Manne-Goehler
PGPascal Geldsetzer
Pascal Geldsetzer
KAKokou Agoudavi
Kokou Agoudavi
GAGlennis Andall-Brereton
Glennis Andall-Brereton
KAKrishna K Aryal
Krishna K Aryal
LJLindsay Jaacks
Lindsay Jaacks
The prevalence of diabetes is increasing rapidly in low- and middle-income countries (LMICs), urgently requiring detailed evidence to guide the response of health systems to this epidemic. In an effort to understand at what step in the diabetes care continuum individuals are lost to care, and how this varies between countries and population groups, this study examined health system performance for diabetes among adults in 28 LMICs using a cascade of care approach. We pooled individual participant data from nationally representative surveys done between 2008 and 2016 in 28 LMICs. Diabetes was defined as fasting plasma glucose ≥ 7.0 mmol/l (126 mg/dl), random plasma glucose ≥ 11.1 mmol/l (200 mg/dl), HbA1c ≥ 6.5%, or reporting to be taking medication for diabetes. Stages of the care cascade were as follows: tested, diagnosed, lifestyle advice and/or medication given (“treated”), and controlled (HbA1c < 8.0% or equivalent). We stratified cascades of care by country, geographic region, World Bank income group, and individual-level characteristics (age, sex, educational attainment, household wealth quintile, and body mass index [BMI]). We then used logistic regression models with country-level fixed effects to evaluate predictors of (1) testing, (2) treatment, and (3) control. The final sample included 847,413 adults in 28 LMICs (8 low income, 9 lower-middle income, 11 upper-middle income). Survey sample size ranged from 824 in Guyana to 750,451 in India. The prevalence of diabetes was 8.8% (95% CI: 8.2%–9.5%), and the prevalence of undiagnosed diabetes was 4.8% (95% CI: 4.5%–5.2%). Health system performance for management of diabetes showed large losses to care at the stage of being tested, and low rates of diabetes control. Total unmet need for diabetes care (defined as the sum of those not tested, tested but undiagnosed, diagnosed but untreated, and treated but with diabetes not controlled) was 77.0% (95% CI: 74.9%–78.9%). Performance along the care cascade was significantly better in upper-middle income countries, but across all World Bank income groups, only half of participants with diabetes who were tested achieved diabetes control. Greater age, educational attainment, and BMI were associated with higher odds of being tested, being treated, and achieving control. The limitations of this study included the use of a single glucose measurement to assess diabetes, differences in the approach to wealth measurement across surveys, and variation in the date of the surveys. The study uncovered poor management of diabetes along the care cascade, indicating large unmet need for diabetes care across 28 LMICs. Performance across the care cascade varied by World Bank income group and individual-level characteristics, particularly age, educational attainment, and BMI. This policy-relevant analysis can inform country-specific interventions and offers a baseline by which future progress can be measured.

1 February 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
KBKaitlyn M. Berry
Kaitlyn M. Berry
JFJessica L. Fetterman
Jessica L. Fetterman
Emelia J. BenjaminEmelia J. Benjamin
Emelia J. Benjamin
ABAruni Bhatnagar
Aruni Bhatnagar
JBJessica L. Barrington-Trimis
Jessica L. Barrington-Trimis
ASAndrew Stokes
Andrew Stokes
In recent years, the proportion of US youths using electronic cigarettes (e-cigarettes), which are considered tobacco products by the US Food and Drug Administration,1 has increased rapidly.2 Past 30-day use of e-cigarettes among high school students increased from 1.5% in 2011 to 20.8% in 2018, with a 78% increase (from 11.7% to 20.8%) from 2017 to 2018.3 These trends have raised concerns that e-cigarettes may lead to the renormalization of tobacco and the initiation of new generations of youths into cigarette smoking,4,5 thus reversing decades of progress in reducing the burden of tobacco-related disease and mortality.6

6 September 2011 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
SLStephen S Lim
Stephen S Lim
NFNancy Fullman
Nancy Fullman
ASAndrew Stokes
Andrew Stokes
NRNirmala Ravishankar
Nirmala Ravishankar
FMFelix Masiye
Felix Masiye
EGEmmanuela Gakidou
Emmanuela Gakidou
Several sub-Saharan African countries have rapidly scaled up the number of households that own insecticide-treated mosquito nets (ITNs). Although the efficacy of ITNs in trials has been shown, evidence on their impact under routine conditions is limited to a few countries and the extent to which the scale-up of ITNs has improved population health remains uncertain. We used matched logistic regression to assess the individual-level association between household ITN ownership or use in children under 5 years of age and the prevalence of parasitemia among children using six malaria indicator surveys (MIS) and one demographic and health survey. We used Cox proportional hazards models to assess the relationship between ITN household ownership and child mortality using 29 demographic and health surveys. The pooled relative reduction in parasitemia prevalence from random effects meta-analysis associated with household ownership of at least one ITN was 20% (95% confidence interval [CI] 3%–35%; I2 = 73.5%, p<0.01 for I2 value). Sleeping under an ITN was associated with a pooled relative reduction in parasitemia prevalence in children of 24% (95% CI 1%–42%; I2 = 79.5%, p0.05 for I2 value). Our findings across a number of sub-Saharan African countries were highly consistent with results from previous clinical trials. These findings suggest that the recent scale-up in ITN coverage has likely been accompanied by significant reductions in child mortality and that additional health gains could be achieved with further increases in ITN coverage in populations at risk of malaria. Please see later in the article for the Editors' Summary

2 November 2018 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
HXHanfei Xu
Hanfei Xu
LCL. Adrienne Cupples
L. Adrienne Cupples
ASAndrew Stokes
Andrew Stokes
CLChing-Ti Liu
Ching-Ti Liu
Numerous investigations of the association between obesity and all-cause mortality have been conducted.1-8 A major potential threat to the validity of such studies is the issue of confounding by illness, in which a preexisting condition alters both weight status and the risk of mortality.9,10 This source of bias, also referred to as reverse causality, has been cited8 as a potential explanation for the findings of a 2013 meta-analysis11 of 97 studies among more than 2.88 million individuals. In that meta-analysis compared with normal weight (body mass index [BMI] of 18.5 to <25, calculated as weight in kilograms divided by height in meters squared), overweight (BMI of 25 to <30) was associated with lower all-cause mortality, and obese I (BMI of 30 to <35) was not associated with higher mortality.

16 January 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SPSamuel H. Preston
Samuel H. Preston
YVYana C. Vierboom
Yana C. Vierboom
ASAndrew Stokes
Andrew Stokes
Significance: Some have speculated that the rising prevalence of obesity may explain why the rate of mortality improvement in the United States has declined relative to other wealthy countries. This paper estimates that rising body mass index (BMI) has reduced the annual rate of improvement in US death rates between 1988 and 2011 by more than half a percentage point—equivalent to a 23% relative reduction in the rate of mortality decline—a large amount by international standards. The increase in BMI has reduced life expectancy at age 40 by 0.9 years in 2011 and accounted for 186,000 excess deaths that year. Rising BMI has prevented the United States from enjoying the full benefits of factors working to improve mortality.

20 May 2021 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
ASAndrew C. Stokes
Andrew C. Stokes
DLDielle J. Lundberg
Dielle J. Lundberg
IEIrma T. Elo
Irma T. Elo
KHKatherine Hempstead
Katherine Hempstead
JBJacob Bor
Jacob Bor
SPSamuel H. Preston
Samuel H. Preston
Background: Coronavirus Disease 2019 (COVID-19) excess deaths refer to increases in mortality over what would normally have been expected in the absence of the COVID-19 pandemic. Several prior studies have calculated excess deaths in the United States but were limited to the national or state level, precluding an examination of area-level variation in excess mortality and excess deaths not assigned to COVID-19. In this study, we take advantage of county-level variation in COVID-19 mortality to estimate excess deaths associated with the pandemic and examine how the extent of excess mortality not assigned to COVID-19 varies across subsets of counties defined by sociodemographic and health characteristics. Methods and findings: In this ecological, cross-sectional study, we made use of provisional National Center for Health Statistics (NCHS) data on direct COVID-19 and all-cause mortality occurring in US counties from January 1 to December 31, 2020 and reported before March 12, 2021. We used data with a 10-week time lag between the final day that deaths occurred and the last day that deaths could be reported to improve the completeness of data. Our sample included 2,096 counties with 20 or more COVID-19 deaths. The total number of residents living in these counties was 319.1 million. On average, the counties were 18.7% Hispanic, 12.7% non-Hispanic Black, and 59.6% non-Hispanic White. A total of 15.9% of the population was older than 65 years. We first modeled the relationship between 2020 all-cause mortality and COVID-19 mortality across all counties and then produced fully stratified models to explore differences in this relationship among strata of sociodemographic and health factors. Overall, we found that for every 100 deaths assigned to COVID-19, 120 all-cause deaths occurred (95% CI, 116 to 124), implying that 17% (95% CI, 14% to 19%) of excess deaths were ascribed to causes of death other than COVID-19 itself. Our stratified models revealed that the percentage of excess deaths not assigned to COVID-19 was substantially higher among counties with lower median household incomes and less formal education, counties with poorer health and more diabetes, and counties in the South and West. Counties with more non-Hispanic Black residents, who were already at high risk of COVID-19 death based on direct counts, also reported higher percentages of excess deaths not assigned to COVID-19. Study limitations include the use of provisional data that may be incomplete and the lack of disaggregated data on county-level mortality by age, sex, race/ethnicity, and sociodemographic and health characteristics. Conclusions: In this study, we found that direct COVID-19 death counts in the US in 2020 substantially underestimated total excess mortality attributable to COVID-19. Racial and socioeconomic inequities in COVID-19 mortality also increased when excess deaths not assigned to COVID-19 were considered. Our results highlight the importance of considering health equity in the policy response to the pandemic.